Strategic Initiative

Slingshot members are tracking this corporate initiative:

Bristol-Myers Squibb (BMY) and Infinity Pharma (INFI) Announce Collaboration Agreement to Study Opdivo and IPI-549 in Patients with Advanced Solid Tumors

Source Link:: http://investor.bms.com/investors/news-and-events/press-releases/press-release-details/2016/Bristol-Myers-Squibb-and-Infinity-Pharmaceuticals-Announce-Clinical-Collaboration-to-Evaluate-Opdivo-nivolumab-in-Combination-with-IPI-549-in-Advanced-Solid-Tumors/default.aspx

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

BMY

100%

INFI

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Slingshot Insights Explained

JOIN FOR FREE TODAY

Strategic Initiative Date

Announcement Date:

Nov 09, 2016

Projected Implementation:

Q4, 2016

Relevance Tracked Until:

Q4, 2018

Related Projects

Don’t see a project related to the strategic initiative you care about?

Related Keywords Opdivo, Ipi-549, Advanced Solid Tumors, Collaboration Agreement